Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 63 citing articles:

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors
Naina Mohamed Pakkir Maideen
Chonnam Medical Journal (2023) Vol. 59, Iss. 2, pp. 115-115
Open Access | Times Cited: 39
Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
Tigran Makunts, Sama M. Alpatty, Kelly C. Lee, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 62
Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
Benjamin Daniels, Sallie‐Anne Pearson, Nicholas A. Buckley, et al.
Therapeutic Advances in Gastroenterology (2020) Vol. 13
Open Access | Times Cited: 40
Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis
Leander Muheim, Andri Signorell, Stefan Markun, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 38
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
Jing Miao, Sandra M. Herrmann
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1834-1844
Open Access | Times Cited: 14
Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids
Tigran Makunts, U Andrew, Rabia S. Atayee, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Clinical feasibility of a new antireflux ablation therapy on gastroesophageal reflux disease (with video)
O.V. Hernández-Mondragón, Raúl Antonio Zamarripa Mottú, Luis Fernando García Contreras, et al.
Gastrointestinal Endoscopy (2020) Vol. 92, Iss. 6, pp. 1190-1201
Closed Access | Times Cited: 37
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
Isaac Cohen, Tigran Makunts, Ruben Abagyan, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Update on Endoscopic Approaches for the Management of Gastroesophageal Reflux Disease.
Zaheer Nabi, Reddy Dn
PubMed (2019) Vol. 15, Iss. 7, pp. 369-376
Closed Access | Times Cited: 23
Do proton pump inhibitors increase mortality? A systematic review and in‐depth analysis of the evidence
Mohamed Ben‐Eltriki, Carolyn J. Green, Malcolm Maclure, et al.
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 5
Open Access | Times Cited: 23
Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
Isaac Cohen, Tigran Makunts, Talar Moumedjian, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Extended Multitarget Pharmacology of Anticancer Drugs
Da Shi, Feroz Khan, Ruben Abagyan
Journal of Chemical Information and Modeling (2019) Vol. 59, Iss. 6, pp. 3006-3017
Open Access | Times Cited: 19
Proton pump inhibitors
Danny Jenkins, Inés Modolell
BMJ (2023), pp. e070752-e070752
Closed Access | Times Cited: 5
Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation
Shuanghui Lu, Jieping Zhao, Xiu Chen, et al.
Chemico-Biological Interactions (2022) Vol. 368, pp. 110219-110219
Closed Access | Times Cited: 8
THE FOCUS ON INCREASED RISK OF FRACTURES IN THEIR PROLONGED USE
Д. И. Трухан, Л. В. Тарасова, Tatyana E. Stepashina
Acta medica Eurasica (2024), Iss. 1, pp. 93-100
Closed Access | Times Cited: 1
Proton pump inhibitors use is associated with a higher prevalence of kidney stones: NHANES 2007–2018
Youjie Zhang, Minghui Liu, Zewu Zhu, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Proton Pump Inhibitors Induced Hyponatremia in a Liver Transplanted Patient—The Role of Deprescribing: A Case Report and Literature Review
Gianmarco Marcianò, Benedetto Caroleo, Luca Catarisano, et al.
Reports — Medical Cases Images and Videos (2024) Vol. 7, Iss. 2, pp. 33-33
Open Access | Times Cited: 1
Proton pump inhibitors and cardiovascular risk: a critical review
Gustavo Duarte, José Luis García López, Franklin Sosa, et al.
Future Cardiology (2024), pp. 1-16
Open Access | Times Cited: 1
Proton pump inhibitors use and risk of incident nephrolithiasis
Wilson Sui, Nicole L. Miller, Edward Gould, et al.
Urolithiasis (2022) Vol. 50, Iss. 4, pp. 401-409
Closed Access | Times Cited: 7
Might proton pump or sodium‐hydrogen exchanger inhibitors be of value to ameliorate SARs‐CoV‐2 pathophysiology?
Kirk P. Conrad
Physiological Reports (2020) Vol. 8, Iss. 24
Open Access | Times Cited: 10
How can proton pump inhibitors damage central and peripheral nervous systems?
Ruben Abagyan, Tigran Makunts
Neural Regeneration Research (2020) Vol. 15, Iss. 11, pp. 2041-2041
Open Access | Times Cited: 9
Myrtle (Myrtus communis L.) fruit syrup for gastroesophageal reflux disease in children: A double‐blind randomized clinical trial
Maryam Sadat Paknejad, Kambiz Eftekhari, Roja Rahimi, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 11, pp. 6369-6376
Closed Access | Times Cited: 8
Proton pump inhibitors and osteoporosis risk: exploring the role of TRPM7 channel
Bhargavi V. Desai, Misbah N. Qadri, Bhavin Vyas
European Journal of Clinical Pharmacology (2021) Vol. 78, Iss. 1, pp. 35-41
Closed Access | Times Cited: 8
Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: COMMENTARY
Paisit Paueksakon, Agnes B. Fogo
Kidney360 (2022) Vol. 3, Iss. 7, pp. 1141-1143
Open Access | Times Cited: 5
Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Very Short-term Use of Proton Pump Inhibitor
Sae Aratani, Takeshi Matsunobu, Takahiro Kawai, et al.
The Keio Journal of Medicine (2020) Vol. 70, Iss. 1, pp. 19-23
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top